Regional grey matter atrophy in clinically isolated syndromes at presentation

Background: The presence and degree of neuronal degeneration already existing in patients at their initial presentation with a clinically isolated syndrome suggestive of multiple sclerosis (CIS) is unclear, and whole brain or whole normalised grey matter analyses have not demonstrated significant atrophy in CIS cohorts at clinical presentation. Voxel-based analyses allow detection of regional atrophy throughout the brain and, therefore, may be sensitive to regional atrophy in CIS patients, and these changes may correspond with clinical disability. Methods: This study used a modified voxel-based morphometry (VBM) method to correct for lesion effects to analyse regional atrophy and perform voxel-wise correlations between volume and clinical metrics in 41 untreated CIS patients at presentation compared with 49 healthy controls. Results: The results confirmed that there was no significant difference in whole normalised grey matter volume between CIS and controls, whereas VBM showed significant areas of bilateral thalamic, hypothalamic, putamen and caudate atrophy. Voxel-wise correlations with clinical measures showed that cerebellar volumes correlated with clinical cerebellar function, nine-hole peg test scores and the Multiple Sclerosis Functional Composite (MSFC) score, and that the MSFC score was also correlated with putamen volume. Lastly, T1 lesion volumes were found to correlate with thalamic and hippocampal atrophy, suggesting a link between white matter lesions and grey matter degeneration at the earliest stages of multiple sclerosis. Conclusions: Atrophy is present in CIS patients at presentations, particularly in the thalamus, and other deep grey matter structures. Furthermore, the correlations with clinical metrics suggest the importance of this atrophy to clinical status and the correlation with T1 lesion load suggests a possible role of Wallerian degeneration.

[1]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[2]  R. Sperling,et al.  Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis , 2007, Multiple sclerosis.

[3]  Chris Frost,et al.  Cerebral Atrophy Measurement in Clinically Isolated Syndromes and Relapsing Remitting Multiple Sclerosis: A Comparison of Registration‐Based Methods , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  Chiara Romualdi,et al.  Cortical atrophy is relevant in multiple sclerosis at clinical onset , 2007, Journal of Neurology.

[5]  Alan J. Thompson,et al.  Localization of grey matter atrophy in early RRMS , 2006, Journal of Neurology.

[6]  Arthur W. Toga,et al.  Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis , 2006, NeuroImage.

[7]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[8]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[9]  Jean-Marc Constans,et al.  Reduced thalamic and cerebellar rest metabolism in relapsing–remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load , 2006, Journal of the Neurological Sciences.

[10]  Dieter Vaitl,et al.  Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS , 2006, NeuroImage.

[11]  David H. Miller,et al.  Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. , 2006, Brain : a journal of neurology.

[12]  Frederik Barkhof,et al.  MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis , 2006, Magnetic resonance in medicine.

[13]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[14]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[15]  G J Barker,et al.  Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. , 2005, Brain : a journal of neurology.

[16]  G. Comi,et al.  Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution , 2005, Neurology.

[17]  G. Barker,et al.  Emergence of thalamic magnetization transfer ratio abnormality in early relapsing—remitting multiple sclerosis , 2005, Multiple sclerosis.

[18]  Maria Assunta Rocca,et al.  A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2005, NeuroImage.

[19]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[20]  A J Thompson,et al.  Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis , 2003, Multiple sclerosis.

[21]  Rohit Bakshi,et al.  Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging Study , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[22]  P. Jezzard,et al.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis , 2003, Neurology.

[23]  Rohit Bakshi,et al.  Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study , 2003, Neuroreport.

[24]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[25]  C. Polman,et al.  Multiple sclerosis functional composite: impact of reference population and interpretation of changes , 2002, Multiple sclerosis.

[26]  A. Yonelinas,et al.  Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients , 2002, Brain and Cognition.

[27]  Nick C Fox,et al.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[28]  G. Barker,et al.  Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.

[29]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[30]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[31]  W. Kamphorst,et al.  Hypothalamic Lesions in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[32]  P M Matthews,et al.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.

[33]  Chris Rorden,et al.  Spatial Normalization of Brain Images with Focal Lesions Using Cost Function Masking , 2001, NeuroImage.

[34]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[35]  J. Simon Brain and Spinal Cord Atrophy in Multiple Sclerosis , 2000, CNS drugs.

[36]  Ludwin Sk,et al.  The neuropathology of multiple sclerosis. , 2000 .

[37]  R Bakshi,et al.  MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation , 2000, Neuroreport.

[38]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[39]  R. Herfkens,et al.  Magnetic resonance imaging in multiple sclerosis: Decreased signal in thalamus and putamen , 1987, Annals of neurology.

[40]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[41]  F. Roncaroli,et al.  Neuropathology of multiple sclerosis , 2012 .